Vivus Wins Its First Fda Drug Approval

The FDA approved a drug to treat erectile dysfunction from Vivus that would compete against Viagra, Cialis and Levitra.

Topics:  fda   vivus   viagra   cialis   levitra   drug   
  • Instant pleasure: Vivus ED pill wins faster-acting 'on demand' label
    The FDA on Thursday approved a revised label for Vivus' erectile dysfunction pill Stendra. Auxilium, which won marketing rights to Stendra in a deal that could be worth as much as $300 million, can now market the drug for use 15 minutes before sex rather ...
    09/17/2014 - 1:00 pm | View Link
  • Vivus Wins FDA Approval for Obesity Drug, After Long, Messy Day
    Vivus has been pushing for more than two years to get its new obesity drug cleared for sale by the FDA, and after one last long, confusing day, it finally got its wish. The FDA said today that the Mountain View, CA-based company (NASDAQ: VVUS) has gotten ...
    07/17/2012 - 12:35 pm | View Link
  • Vivus, Onyx, Amarin Await Key Dates in July
    ... on possible US approval of its drug Kyprolis for multiple myeloma in patients who received other treatments. A panel of FDA advisers unanimously backed the treatment last month. (See Onyx Pharmaceuticals Wins US Panel's Backing for Cancer Drug.)
    07/2/2012 - 9:50 am | View Link
  • Vivus Obesity Pill Wins FDA Panel Nod; NeuroSearch Surges
    Competitor Orexigen Therapeutics Inc. also rose after the Food and Drug Administration advisers voted 20-2 yesterday that Qnexa’s benefits outweigh its risks. While the FDA isn’t required to follow the panel’s recommendation, it often does.
    02/23/2012 - 3:23 am | View Link
  • Vivus' Weight-Loss Drug Faces Key U.S. Test
    If Qnexa wins the FDA's green light, that could more than double. Analysts estimate Vivus' drug could take in nearly $689 million in sales by 2014, according to consensus forecast data from Thomson Reuters. It would be the second U.S. drug for the biotech ...
    07/14/2010 - 1:00 pm | View Link
  • More
  • BioWorld | The Daily Biopharmaceutical News Source
    Contains business, science, and regulatory news, including mergers and collaborations, FDA hearings and results, and research breakthroughs. Need subscription to use.
    11/29/2015 - 2:38 am | View Website
  • Vivus
    View detailed financial information, real-time news, videos, quotes and analysis on Vivus (NASDAQ:VVUS). Explore commentary on Vivus and hear what the experts at ...
    11/28/2015 - 10:57 pm | View Website
  • Bloomberg
    The daily online Bloomberg report gives you the latest headlines from around the world, current market data annd personal finance advice, politics and top videos.
    11/28/2015 - 9:16 pm | View Website
  • CafePharma
    CP Wire. Submit an article to cafepharma's CP Wire. Click here to find out more. Breaking Healthcare News - powered by Seeking Alpha
    11/28/2015 - 6:24 pm | View Website
  • Takeda
    Takeda Pharmaceutical's top cancer prospect won a speedy FDA approval, wading into a crowded market for multiple myeloma treatments with hopes of duplicating the ...
    11/28/2015 - 10:25 am | View Website
  • More
Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More U.s. News